Jupiter Asset Management’s Kura Oncology KURA Stock Holding History

Jupiter Asset Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.59M	Buy	+509,886	New	+$4.81M	0.03%	358
2024 Q1	–	Sell	-57,877	Closed	-$832K	–	479
2023 Q4	$832K	Hold	57,877	–	–	0.01%	395
2023 Q3	$528K	Buy	57,877 +40,560	+234%	+$412K	0.01%	429
2023 Q2	$183K	Buy	+17,317	New	+$205K	﹤0.01%	489

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Jupiter Asset Management's KURA Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Kura Oncology (KURA) in Q2 2026: 509,886 shares worth $5.59M. The stake represents 0.03% of the portfolio and ranks #358 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in KURA as recently as Q4 2023.

Jupiter Asset Management first reported a position in KURA in Q2 2023 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Jupiter Asset Management held 509,886 shares of Kura Oncology worth $5.59M as of Q2 2026.
Kura Oncology was a new Jupiter Asset Management position in Q2 2026.
Kura Oncology made up 0.03% of Jupiter Asset Management's portfolio in Q2 2026, its #358 holding.
Jupiter Asset Management first reported a position in Kura Oncology in Q2 2023 and has held it in 4 quarters since.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.